NO924925D0 - Bradykinin-antagonister for behandling av akutt betennelse i bukspyttkjertelen - Google Patents

Bradykinin-antagonister for behandling av akutt betennelse i bukspyttkjertelen

Info

Publication number
NO924925D0
NO924925D0 NO924925A NO924925A NO924925D0 NO 924925 D0 NO924925 D0 NO 924925D0 NO 924925 A NO924925 A NO 924925A NO 924925 A NO924925 A NO 924925A NO 924925 D0 NO924925 D0 NO 924925D0
Authority
NO
Norway
Prior art keywords
gly
hyp
pro
substituted
benzoyl
Prior art date
Application number
NO924925A
Other languages
English (en)
Other versions
NO924925L (no
Inventor
Thomas Griesbacher
Fred Lembeck
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO924925D0 publication Critical patent/NO924925D0/no
Publication of NO924925L publication Critical patent/NO924925L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/043—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/18—Kallidins; Bradykinins; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
NO92924925A 1991-12-21 1992-12-18 Bradykinin-antagonister for behandling av akutt betennelse i bukspyttkjertelen NO924925L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91122055 1991-12-21

Publications (2)

Publication Number Publication Date
NO924925D0 true NO924925D0 (no) 1992-12-18
NO924925L NO924925L (no) 1993-06-22

Family

ID=8207466

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92924925A NO924925L (no) 1991-12-21 1992-12-18 Bradykinin-antagonister for behandling av akutt betennelse i bukspyttkjertelen

Country Status (27)

Country Link
US (1) US5670619A (no)
EP (1) EP0548825B1 (no)
JP (1) JP3588472B2 (no)
KR (1) KR930012034A (no)
CN (1) CN1073603A (no)
AT (1) ATE152733T1 (no)
AU (1) AU662188B2 (no)
BG (1) BG97168A (no)
BR (1) BR9205062A (no)
CA (1) CA2085781C (no)
CY (1) CY2116B1 (no)
CZ (1) CZ375692A3 (no)
DE (1) DE69219574T2 (no)
DK (1) DK0548825T3 (no)
ES (1) ES2101017T3 (no)
FI (1) FI925782A (no)
GR (1) GR3024179T3 (no)
HU (1) HU214056B (no)
IL (1) IL104163A0 (no)
MA (1) MA22743A1 (no)
MX (1) MX9207440A (no)
NO (1) NO924925L (no)
PL (1) PL297044A1 (no)
SI (1) SI9200406A (no)
TW (1) TW199863B (no)
YU (1) YU108192A (no)
ZA (1) ZA929829B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7105172B1 (en) 1999-11-18 2006-09-12 Bolla John D Treatment of rosacea
US20040248809A1 (en) * 2003-02-07 2004-12-09 Aventis Pharma Deutschland Gmbh Use of antagonists of the bradykinin B2 receptor for the treatment of osteoarthrosis
RU2425669C1 (ru) * 2010-04-13 2011-08-10 Общество С Ограниченной Ответственностью "Гамаветфарм" Средство для профилактики и лечения острого и хронического панкреатита

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT387393B (de) * 1978-07-18 1989-01-10 Kabi Ab Verfahren zur herstellung von neuen tripeptidderivaten
US4801613A (en) * 1985-06-13 1989-01-31 Nova Technology Limited Partnership Bradykinin antagonist peptides
US4693993A (en) * 1985-06-13 1987-09-15 Stewart John M Bradykinin antagonist peptides
US4923963A (en) * 1987-09-02 1990-05-08 Nova Technology Limited Partnership Bradykinin antagonist peptides
US5162497A (en) * 1987-09-24 1992-11-10 The Administrators Of The Tulane Educational Fund Bradykinin analogs with non-peptide bond
IE63490B1 (en) * 1988-11-24 1995-05-03 Hoechst Ag Peptides having bradykinin antagonist action
DE3926822A1 (de) * 1989-08-14 1991-02-21 Hoechst Ag Peptide mit bradykinin-antagonistischer wirkung
DE4013270A1 (de) * 1990-04-26 1991-10-31 Hoechst Ag Peptide mit bradykinin-antagonistischer wirkung
WO1991009055A1 (en) * 1989-12-08 1991-06-27 Boston University Acylated bradykinin antagonists and uses therefor
EP0451791A2 (de) * 1990-04-12 1991-10-16 Hoechst Aktiengesellschaft Langwirksame Liposomenpräparate von Peptidarzneistoffen und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
KR930012034A (ko) 1993-07-20
TW199863B (no) 1993-02-11
CZ375692A3 (en) 1993-12-15
ES2101017T3 (es) 1997-07-01
IL104163A0 (en) 1993-05-13
SI9200406A (en) 1993-06-30
CN1073603A (zh) 1993-06-30
MX9207440A (es) 1993-07-01
DK0548825T3 (da) 1997-11-03
ZA929829B (en) 1994-02-16
FI925782A (fi) 1993-06-22
BR9205062A (pt) 1993-09-28
GR3024179T3 (en) 1997-10-31
JP3588472B2 (ja) 2004-11-10
HU9204074D0 (en) 1993-04-28
AU3021292A (en) 1993-06-24
DE69219574T2 (de) 1997-11-13
US5670619A (en) 1997-09-23
EP0548825A1 (en) 1993-06-30
JPH05255107A (ja) 1993-10-05
NO924925L (no) 1993-06-22
HU214056B (en) 1997-12-29
CA2085781C (en) 2003-09-23
AU662188B2 (en) 1995-08-24
ATE152733T1 (de) 1997-05-15
PL297044A1 (en) 1993-09-06
FI925782A0 (fi) 1992-12-18
CA2085781A1 (en) 1993-06-22
BG97168A (bg) 1993-12-24
YU108192A (sh) 1995-12-04
HUT63336A (en) 1993-08-30
MA22743A1 (fr) 1993-07-01
CY2116B1 (en) 2002-04-26
DE69219574D1 (de) 1997-06-12
EP0548825B1 (en) 1997-05-07

Similar Documents

Publication Publication Date Title
ATE171712T1 (de) Neuartiger menschlicher proteaseinhibitor vom kunitz-typ und entsprechende varianten
ATE219103T1 (de) Cnp-analoge peptide und ihre verwendung
SI1755630T1 (sl) Farmacevtski sestavki iz lisaja bradovca (Usnea barbata) in sentjanzevke (Hypericum perforatum) kottudi njihova uporaba
ATE198603T1 (de) Bivalente thrombininhibitore
NO924925D0 (no) Bradykinin-antagonister for behandling av akutt betennelse i bukspyttkjertelen
DE69232698D1 (de) Neuer megakaryocyten-verstärker
TH13940A (th) เบรดีไคนิน-แอนตาโกนิส สำหรับใช้บำบัดตับอ่อนอักเสบเฉียบพลัน
TH13940EX (th) เบรดีไคนิน-แอนตาโกนิส สำหรับใช้บำบัดตับอ่อนอักเสบเฉียบพลัน
RU92016227A (ru) Лекарственная композиция, включающая антагонисты брадикинина, используемая в лечении острого панкреатита, способ ее получения и использование
TW340849B (en) Novel cyclopeptides and pharmaceutical compositions as integrin inhibitors comprizing the same
ES541194A0 (es) Un procedimiento de preparacion de inhibidores de la renina que contienen estatina o sus derivados.
EP1679081A3 (de) Therapeutische Verwendung von Cephaibolen